Access & Value (A&V), Outcomes and Evidence (O&E) Manager

Start free →

Or apply yourself on the official page →

About the role

Role Summary: You will be part of Pfizer’s dynamic market access, Access & Value UK, team and will have the important role of evaluating and delivering on the evidence needs for pre-marketed medicines in the UK. A&V comprises three sub-teams – Health Technology Assessment (HTA), Asset & Access (A&A) and Outcomes & Evidence (O&E). This role sits in the O&E team who lead the evidence generation needs to support reimbursement and access in the UK. In this role, the primary function is to lead an optimised evidence strategy for the UK’s HTA submissions. This requires the individual to identify gaps in evidence, prioritise those which will make a difference to the likelihood of reimbursement and, if required, plan and deliver new real-world evidence (RWE) studies (such treatment patterns and healthcare resource use). To achieve this, the individual works hand-in-hand HTA and A&A to drive the overall reimbursement and access strategy which requires strong cross-functional engagement to ensure the strategies are aligned with the UK launch and wider Global strategies. At Manager level, the individual is expected to be supported by a senior colleague from within the O&E team to develop their research methods capabilities, their understanding of market access and the applicability of RWE to optimising reimbursement. As such, we are seeking an individual who has experience of supporting RWE studies, preferably retrospective database studies in the UK and can demonstrate an understanding of robust scientific and methodological approaches to study design. An understanding of HTA/market access is preferable. They will be managing multiple pipeline assets and will therefore need excellent time management and prioritisation skills. Strong interpersonal skills to positively collaborate with multiple internal stakeholders and key external stakeholders will also be required to ensure that our work is comprehensive and valuable to patients as well as the UK business. Role responsibilities : • Develop thorough evidence gap analyses and corresponding evidence strategies (i.e. solutions for addressing gaps) for assets across different therapy areas • Work with Outcomes Research scientists in O&E to identify and support patient-centered study requirements for reimbursement • Develop business cases to seek funding for studies that clearly and succinctly convey the impact of evidence generation studies on reimbursement and access outcomes • Lead RWE projects, with senior support, to a high-standard, end-to-end from conceptualisation to dissemination including management of vendors or internal teams to conduct RWE projects, management of internal processes to ensure compliance with SOPs and ABPI Code of Conduct where relevant • Maintain excellent working relationships with cross-functional teams assigned to an asset to ensure evidence plans remain strategic for the business, keep them updated with evolutions in relevant evidence from across the business and report on progress with active studies • Maintain and develop a working knowledge of advancements in UK datasets, analytical platforms and RWE methods and that can be utilised to accelerate or enhance evidence generation • Source or provide appropriate training to develop skills and talent in RWE methodology. Qualifications: Must-Have • Post-graduate qualification in epidemiology/public health or other relevant degree • Some relevant experience across industry and/or consultancy in RWE and HTA/market access • Supported/led observational research including UK databases (e.g. CPRD/HES/SACT) with deep understanding of study design, study protocols and analysis plans • Strong project management, strategic and analytic skills, along with excellent interpersonal skills • Strong internal and ext

View the official posting →